Details of the Drug

General Information of Drug (ID: DMISOUJ)

• Drug Name: TA-383
• Synonyms: Cis-2-(4-Chlorophenyl)-4,5-diphenyl-2-imidazoline hydrochloride; Cis-2-(4-Chlorophenyl)-4,5-diphenyl-4,5-dihydro-1H-imidazole hydrochloride

Indication

Disease Entry	ICD 11	Status	REF
Arthritis	FA20	Discontinued in Phase 2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C21H18Cl2N2
  Canonical SMILES: C1=CC=C(C=C1)C2C(N=C(N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4.Cl
  InChI: InChI=1S/C21H17ClN2.ClH/c22-18-13-11-17(12-14-18)21-23-19(15-7-3-1-4-8-15)20(24-21)16-9-5-2-6-10-16;/h1-14,19-20H,(H,23,24);1H/t19-,20+
  InChIKey: BRBLXQRJSVLYHU-AMDBCLDASA-N
• Cross-matching ID:
  PubChem CID: 131180
  CAS Number: 130186-26-4
  TTD ID: D0R2CM

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002178)